| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $3.95B | +29.4% |
| Cost of Revenue | $991.5M | +31.2% |
| Gross Profit | $2.96B | +28.8% |
| R&D Expense | $1.08B | +40.1% |
| SG&A Expense | $482.3M | +22.8% |
| Operating Income | -$120.4M | -5936.6% |
| Pre-tax Income | $54.5M | -55.6% |
| Income Tax | $71.1M | +120.7% |
| Net Income | -$19.3M |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.32B | +28.1% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $1.13B | +32.3% |
| Current Assets | $6.11B | +28.5% |
| Total Assets | $8.70B | +30.9% |
| Current Liabilities | $3.46B | +28.3% |
| Long-term Debt | $744.0M | +0.2% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.38B | +18.5% |
| Capital Expenditures | $254.9M | +44.4% |
| Investing Cash Flow | -$536.6M | -57.5% |
| Financing Cash Flow | $107.2M | +15.1% |
| Free Cash Flow | $1.13B | +13.9% |
| -121.6% |
| EPS (Basic) | -$0.08 | -121.6% |
| EPS (Diluted) | -$0.08 | -121.6% |
| Total Liabilities |
| $5.38B |
| +24.9% |
| Stockholders' Equity | $3.28B | +42.3% |